Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Inositol monophosphatase 1 | Starlite/ChEMBL | No references |
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Conserved protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.214 | 0.3954 | 0.5 |
Echinococcus granulosus | Transglutaminase | 0.214 | 0.3954 | 1 |
Mycobacterium tuberculosis | Long conserved protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.214 | 0.3954 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.214 | 0.3954 | 1 |
Echinococcus multilocularis | Transglutaminase | 0.214 | 0.3954 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.214 | 0.3954 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.214 | 0.3954 | 0.5 |
Giardia lamblia | Transglutaminase/protease, putative | 0.214 | 0.3954 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.214 | 0.3954 | 0.5 |
Brugia malayi | Thioredoxin family protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.214 | 0.3954 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.214 | 0.3954 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.214 | 0.3954 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.5623 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | = 1.122 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.